The tests offer a fast and easy way for physicians to learn whether a patient with symptoms of cognitive decline also has the brain changes associated with Alzheimer’s. Evidence of those brain changes is required before doctors can prescribe one of two recently approved drugs...
The filters of modern news media create disparate, personalized perceptions of science. Researchers at CALS are looking for ways to craft messages that resonate with people of all viewpoints....
Hosting a robust onboarding process for introducing entry-level hires to their job responsibilities is clearly a best practice for any industry. Taking things one step further by onboarding both new and promoted employees who are at any step on their career ladder is proving to...
The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older....
Today, the summit organizers, UW Health and Epic, published a report detailing key recommendations for policymakers as they consider the future of AI in health care....
A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease, a new study found....
It was a landmark moment for the psychedelic movement: The VA's top doctor stood on stage, praising advocates who have spent decades promoting the healing potential of mind-altering drugs....
Effective August 1, UW Health Clinical Laboratories will be making changes to the on-site phlebotomy training option....
Microsoft continues to deepen its work in healthcare AI. The tech giant is now collaborating with academic medical systems Mass General Brigham and the University of Wisconsin-Madison to advance AI in medical imaging....
The discovery of a brain circuit involved in the pain-relieving effect of placebos could lead to new treatments....
